Scheduled imaging studies provide little help detecting relapse of aggressive lymphoma

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, an abnormal physical exam or an abnormal blood test at the time of relapse, the researchers say. The findings will be presented at the American Society of Clinical Oncology annual meeting May 31-June 4 in Chicago.

"Our results were surprising because the current standard-of-care is to include scans for the follow-up of this disease," says lead author Carrie Thompson, M.D., a Mayo Clinic hematologist. "We found that scans detected in only a handful of patients who didn't have any of those other signs or symptoms. I think our study suggests that we are getting closer to understanding how to optimize follow-up in this patient population."

Diffuse large B-cell lymphoma is the most common type of , with nearly 20,000 new cases diagnosed in the United States each year. The aggressive can be cured if treated in its early stages. The cancer will come back in 20 to 30 percent of cases, and the best strategy for catching that relapse is unclear. In this study, Dr. Thompson and her colleagues looked at patients in remission to identify how relapses were detected.

Researchers followed 537 patients treated with anthracycline-based immunochemotherapy and enrolled in the Mayo Clinic/University of Iowa Special Program of (SPORE) Molecular Epidemiology Resource. Of the 109 patients who relapsed, 62 percent went to the doctor earlier than a planned follow-up visit due to the re-emergence of symptoms such as enlarged lymph nodes, fever, night sweats, pain or weight loss. At the time of relapse, 68 percent had symptoms, 42 percent had an abnormal , and 55 percent had an abnormal . Performing surveillance scans detected relapse in only eight patients whose symptoms had not yet started to reappear.

Dr. Thompson is now interested in surveying physicians and patients to assess their attitudes and beliefs surrounding the use of scans during remission. Her previous work suggested that patients experience a significant amount of anxiety waiting for a follow-up scan.

"Sometimes scans can provide reassurance, but, at the same time, the anticipation of a scan can provoke quite a bit of anxiety," Dr. Thompson says. "And we know from this data that scans detected relapses only in a minority of patients. So we need to think about how we can individualize care to particular , keeping in mind their disease, their experience and their fears. Further studies are necessary to determine the optimal follow-up strategy."

More information: www.asco.org/

Related Stories

Brain patterns may help predict relapse risk for alcoholism

date May 02, 2013

(Medical Xpress)—Distinct patterns of brain activity are linked to greater rates of relapse among alcohol dependent patients in early recovery, a study has found. The research, supported by the National Institutes of Health, ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

date Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.